1   Preface
2   Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction
    4.1    Overview
    4.2    Key Industry Trends
5   Global Bioanalytical Testing Services Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Molecule Type
    6.1    Small Molecule
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Large Molecule
        6.2.1 Market Trends
        6.2.2 Key Segments
           6.2.2.1 LC-MS Studies
           6.2.2.2 Immunoassays
           6.2.2.3 Others
        6.2.3 Market Forecast
7   Market Breakup by Test Type
    7.1    ADME
        7.1.1 Market Trends
        7.1.2 Key Segments
           7.1.2.1 In-Vivo
           7.1.2.2 In-Vitro
        7.1.3 Market Forecast
    7.2    PK
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    PD
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Bioavailability
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Bioequivalence
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    Others
        7.6.1 Market Trends
        7.6.2 Market Forecast
8   Market Breakup by Workflow
    8.1    Sample Preparation
        8.1.1 Market Trends
        8.1.2 Key Segments
           8.1.2.1 Protein Precipitation
           8.1.2.2 Liquid-Liquid Extraction
           8.1.2.3 Solid Phase Extraction
        8.1.3 Market Forecast
    8.2    Sample Analysis
        8.2.1 Market Trends
        8.2.2 Key Segments
           8.2.2.1 Hyphenated Technique
           8.2.2.2 Chromatographic Technique
           8.2.2.3 Electrophoresis
           8.2.2.4 Ligand Binding Assay
           8.2.2.5 Mass Spectrometry
           8.2.2.6 Nuclear Magnetic Resonance
        8.2.3 Market Forecast
    8.3    Others
        8.3.1 Market Trends
        8.3.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis
    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape
    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Almac Group
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 SWOT Analysis
        14.3.2    Charles River Laboratories International Inc.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    Frontage Laboratories Inc.
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
        14.3.4    ICON plc
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    Intertek Group plc
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    Laboratory Corporation of America Holdings
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Pace Analytical Services LLC
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
        14.3.8    PPD Inc.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
        14.3.9    PRA Health Sciences
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 SWOT Analysis
        14.3.10    SGS SA
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
        14.3.11    Syneos Health
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 Financials
           14.3.11.4 SWOT Analysis
        14.3.12    Toxikon Corporation
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


 
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			